Disc Medicine Stock Analysis
| IRON Stock | 64.48 1.09 1.66% |
IPO Date 12th of August 2020 | 200 Day MA 67.8569 | 50 Day MA 80.6344 | Beta 2.584 |
At this time, Disc Medicine's Total Debt To Capitalization is very stable compared to the past year. As of the 19th of February 2026, Debt Equity Ratio is likely to grow to 0.06, while Net Debt is likely to drop (153.5 M). With a high degree of financial leverage come high-interest payments, which usually reduce Disc Medicine's Earnings Per Share (EPS).
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.0694 | Current Value 0.066 | Quarterly Volatility 1.25813803 |
Disc Medicine is undervalued with Real Value of 80.97 and Target Price of 103.42. The main objective of Disc Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Disc Medicine is worth, separate from its market price. There are two main types of Disc Medicine's stock analysis: fundamental analysis and technical analysis.
The Disc Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Disc Medicine is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Disc Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Disc Stock Analysis Notes
About 92.0% of the company shares are owned by institutional investors. The book value of Disc Medicine was currently reported as 16.38. The company recorded a loss per share of 5.37. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. To learn more about Disc Medicine call Esq JD at 617 674 9274 or check out https://www.discmedicine.com.Disc Medicine Investment Alerts
| Disc Medicine generated a negative expected return over the last 90 days | |
| Disc Medicine has high historical volatility and very poor performance | |
| Net Loss for the year was (109.36 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Disc Medicine generates negative cash flow from operations | |
| Disc Medicine has a frail financial position based on the latest SEC disclosures | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Pamela Stephenson Sells 5,531 Shares of Disc Medicine Stock |
Disc Largest EPS Surprises
Earnings surprises can significantly impact Disc Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-10 | 2022-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2024-03-21 | 2023-12-31 | -0.78 | -0.9 | -0.12 | 15 | ||
2023-08-11 | 2023-06-30 | -0.86 | -0.74 | 0.12 | 13 |
Disc Medicine Environmental, Social, and Governance (ESG) Scores
Disc Medicine's ESG score is a quantitative measure that evaluates Disc Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Disc Medicine's operations that may have significant financial implications and affect Disc Medicine's stock price as well as guide investors towards more socially responsible investments.
Disc Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.48 B.Disc Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.20) | (0.21) | |
| Return On Capital Employed | (0.32) | (0.30) | |
| Return On Assets | (0.20) | (0.21) | |
| Return On Equity | (0.28) | (0.27) |
Management Efficiency
Disc Medicine has return on total asset (ROA) of (0.2261) % which means that it has lost $0.2261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3478) %, meaning that it created substantial loss on money invested by shareholders. Disc Medicine's management efficiency ratios could be used to measure how well Disc Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of February 2026, Return On Tangible Assets is likely to drop to -0.21. In addition to that, Return On Capital Employed is likely to grow to -0.3. At this time, Disc Medicine's Total Assets are very stable compared to the past year. As of the 19th of February 2026, Other Assets is likely to grow to about 217.3 K, while Net Tangible Assets are likely to drop (60.7 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.46 | 17.10 | |
| Tangible Book Value Per Share | 14.46 | 17.10 | |
| Enterprise Value Over EBITDA | (16.86) | (16.02) | |
| Price Book Value Ratio | 3.55 | 3.73 | |
| Enterprise Value Multiple | (16.86) | (16.02) | |
| Price Fair Value | 3.55 | 3.73 | |
| Enterprise Value | 1.4 B | 1.5 B |
The management team at Disc Medicine has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Technical Drivers
As of the 19th of February, Disc Medicine shows the Mean Deviation of 2.69, standard deviation of 4.55, and Variance of 20.72. Disc Medicine technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Disc Medicine Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
Disc Medicine Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Disc Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Disc Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Disc Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Disc Medicine Outstanding Bonds
Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Disc bonds can be classified according to their maturity, which is the date when Disc Medicine has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| DISNEY WALT NEW Corp BondUS25468PCP99 | View | |
| DISNEY WALT NEW Corp BondUS25468PCR55 | View | |
| US254687DH68 Corp BondUS254687DH68 | View | |
| DISNEY WALT NEW Corp BondUS25468PBW59 | View | |
| WALT DISNEY CO Corp BondUS254687FL52 | View | |
| WALT DISNEY CO Corp BondUS254687FM36 | View | |
| US254687FB70 Corp BondUS254687FB70 | View | |
| US254687EV44 Corp BondUS254687EV44 | View |
Disc Medicine Predictive Daily Indicators
Disc Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Disc Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 55215.81 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 65.3 | |||
| Day Typical Price | 65.02 | |||
| Price Action Indicator | (1.36) | |||
| Period Momentum Indicator | (1.09) | |||
| Relative Strength Index | 54.04 |
Disc Medicine Corporate Filings
8K | 17th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 13th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 21st of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 12th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of January 2026 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 5th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 29th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Disc Medicine Forecast Models
Disc Medicine's time-series forecasting models are one of many Disc Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Disc Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Disc Medicine Bond Ratings
Disc Medicine financial ratings play a critical role in determining how much Disc Medicine have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Disc Medicine's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (4.87) | Unlikely Manipulator | View |
Disc Medicine Total Assets Over Time
Disc Medicine Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Disc Medicine uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Disc Medicine Debt Ratio | 6.6 |
Disc Medicine Corporate Bonds Issued
Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the most significant components of the U.S. bond market and are considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt.
Disc Short Long Term Debt Total
Short Long Term Debt Total |
|
About Disc Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Disc Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Disc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Disc Medicine. By using and applying Disc Stock analysis, traders can create a robust methodology for identifying Disc entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current Disc Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Disc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Disc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 103.42 | Strong Buy | 11 | Odds |
Most Disc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Disc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Disc Medicine, talking to its executives and customers, or listening to Disc conference calls.
Disc Stock Analysis Indicators
Disc Medicine stock analysis indicators help investors evaluate how Disc Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Disc Medicine shares will generate the highest return on investment. By understating and applying Disc Medicine stock analysis, traders can identify Disc Medicine position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 360.6 M | |
| Long Term Debt | 28.3 M | |
| Common Stock Shares Outstanding | 27.6 M | |
| Total Stockholder Equity | 443.6 M | |
| Total Cashflows From Investing Activities | -292.3 M | |
| Tax Provision | 355 K | |
| Property Plant And Equipment Net | 2.3 M | |
| Cash And Short Term Investments | 489.9 M | |
| Cash | 192.4 M | |
| Accounts Payable | 7.9 M | |
| Net Debt | -162.4 M | |
| 50 Day M A | 80.6344 | |
| Total Current Liabilities | 23.3 M | |
| Other Operating Expenses | 129.7 M | |
| Non Current Assets Total | 3.2 M | |
| Non Currrent Assets Other | 838 K | |
| Stock Based Compensation | 16.8 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Biotechnology sector continue expanding? Could Disc diversify its offerings? Factors like these will boost the valuation of Disc Medicine. Market participants price Disc higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Disc Medicine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Disc Medicine using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Disc Medicine's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Disc Medicine's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Disc Medicine's market price signifies the transaction level at which participants voluntarily complete trades.